Abstract
Novel, selective M2 muscarinic antagonists, which replace the metabolically labile styrenyl moiety of the prototypical M2 antagonist 1 with an ether linkage, were synthesized. A detailed SAR study in this class of compounds has yielded highly active compounds that showed M2 Ki values of < 1.0 nM and >100-fold selectivity against M1, M3, and M5 receptors.
MeSH terms
-
Acetylcholine / agonists*
-
Alkenes / chemical synthesis
-
Drug Design
-
Ether / analogs & derivatives*
-
Ether / pharmacology*
-
Humans
-
Muscarinic Antagonists / chemical synthesis
-
Muscarinic Antagonists / pharmacology*
-
Protein Binding
-
Receptor, Muscarinic M1
-
Receptor, Muscarinic M2
-
Receptor, Muscarinic M3
-
Receptor, Muscarinic M5
-
Receptors, Muscarinic / drug effects*
-
Structure-Activity Relationship
Substances
-
Alkenes
-
Muscarinic Antagonists
-
Receptor, Muscarinic M1
-
Receptor, Muscarinic M2
-
Receptor, Muscarinic M3
-
Receptor, Muscarinic M5
-
Receptors, Muscarinic
-
Ether
-
Acetylcholine